A growing number of lawsuits have been filed against the Icelandic drug maker over charges that its recalled heart med was dangerous and defective, and led to one death, the Associated Press reports. Here is the latest suit.

The ligitation occurs not longer after Actavis this past April began a nationwide recall of all strengths of the Digitek pills, which are distributed by Mylan Pharmaceuticals and UDL Laboratories. Those two drugmakers were also named as defendants, and similar lawsuits have been filed in West Virginia and California.

Actavis said at the time that some tablets may have been double the usual thickness and so would contain twice the active ingredient, posing a risk of toxicity with symptoms from nausea and dizziness to low blood pressure and cardiac instability. The drugmaker noted that death can result from excessive intake of the active ingredient and that several reports of injuries had been received.

One of the New Jersey lawsuits, filed by the estate of Margret Lucille Crooker of Kemp, Texas, claimed the drug caused her “serious physical injury, pain and suffering” and she died on March 15.

According to published reports, a lawsuit filed by an Indiana woman hospitalized from an allegedly toxic overdose of Digitek in June, said that an FDA inspection at an Actavis plant had found deviations from good manufacturing practices that led to adulteration of drugs.

On Friday, an Actavis spokeswoman in the drugmaker’s New Jersey unit declined to comment on pending litigation, according to the AP.